Skip navigation

TUESDAY, DECEMBER 5, 2017

8:00

Continental Breakfast

9:00

Chairperson’s Opening Remarks

Sabrina Yohai
Vice President, Corporate-Legal
Vertex Pharmaceuticals

9:15

ROUNDTABLE DISCUSSION The Latest Developments in State Pricing Transparency and
Disclosure Legislation — A Look Back at 2017 and Future Implications

MODERATOR:

John T. Gould
Partner
Arnold & Porter Kaye Scholer

PANELISTS:

Debbie A. Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Corporate-Legal
Vertex Pharmaceuticals

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

10:15

DEEP-DIVE SESSION Explore the Legal and Enforcement Implications of State Pricing and Transparency Laws

I State-by-State Analysis —
What You Need to Know to Ensure Reporting Compliance

William A. Sarraille
Partner
Sidley Austin LLP

11:00

Networking and Refreshment Break

11:30

II State Waivers and Future Legal Implications

William A. Sarraille
Partner
Sidley Austin LLP

12:15

Networking Luncheon

1:30

Compliance and Operational Impact Analysis for State Price Transparency Tracking and Reporting Obligations

Regina Alvarado
Senior Manager
Deloitte & Touche LLP

Colleen Malone
Senior Consultant
Deloitte & Touche LLP

2:30

Networking and Refreshment Break

3:00

Understand Value-Based Frameworks and the Impact on Drug Pricing

Ambarish J. Ambegaonkar, PhD
Founder and CEO
Apperture LLC

Leora Schiff
Principal
Altius Strategy Consulting

4:00

Wrap-Up Roundtable Discussion Drug Pricing Scrutiny — Managing the “New” Normal

MODERATOR:

William A. Sarraille
Partner
Sidley Austin LLP

PANELISTS:

Mark Tyndall
Vice President, Government Affairs, Policy and Advocacy
Mallinckrodt Pharmaceuticals

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following the final session

Want more agenda details? Download the brochure.

TUESDAY, DECEMBER 5, 2017

8:00

Continental Breakfast

9:00

Chairperson’s Opening Remarks

Sabrina Yohai
Vice President, Corporate-Legal
Vertex Pharmaceuticals

9:15

ROUNDTABLE DISCUSSION The Latest Developments in State Pricing Transparency and
Disclosure Legislation — A Look Back at 2017 and Future Implications

MODERATOR:

John T. Gould
Partner
Arnold & Porter Kaye Scholer

PANELISTS:

Debbie A. Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Corporate-Legal
Vertex Pharmaceuticals

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

10:15

DEEP-DIVE SESSION Explore the Legal and Enforcement Implications of State Pricing and Transparency Laws

I State-by-State Analysis —
What You Need to Know to Ensure Reporting Compliance

William A. Sarraille
Partner
Sidley Austin LLP

11:00

Networking and Refreshment Break

11:30

II State Waivers and Future Legal Implications

William A. Sarraille
Partner
Sidley Austin LLP

12:15

Networking Luncheon

1:30

Compliance and Operational Impact Analysis for State Price Transparency Tracking and Reporting Obligations

Regina Alvarado
Senior Manager
Deloitte & Touche LLP

Colleen Malone
Senior Consultant
Deloitte & Touche LLP

2:30

Networking and Refreshment Break

3:00

Understand Value-Based Frameworks and the Impact on Drug Pricing

Ambarish J. Ambegaonkar, PhD
Founder and CEO
Apperture LLC

Leora Schiff
Principal
Altius Strategy Consulting

4:00

Wrap-Up Roundtable Discussion Drug Pricing Scrutiny — Managing the “New” Normal

MODERATOR:

William A. Sarraille
Partner
Sidley Austin LLP

PANELISTS:

Mark Tyndall
Vice President, Government Affairs, Policy and Advocacy
Mallinckrodt Pharmaceuticals

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following the final session